Several pivotal and late-stage trials, which are expected to enroll over 100 patients and more, were among the list of trial initiations in August, as recorded by Informa's Meddevicetracker , Mai
IN VITRO DIAGNOSTICS Agendia BV Agendia raises $65mm through late-stage round A year after withdrawing its IPO filing, molecular diagnostics firm Agendia BV has raised $65mm in what appears to
IN VITRO DIAGNOSTICS Alliances Abaxis Inc. Abbott Laboratories Inc. Abbott Point of Care Abaxis Inc. has licensed fellow POC blood analysis systems company Abbott Point of Care exclusive right